AB SCIEX and the University of Geneva's Mass Spectrometry Centre Collaborate to Improve Drug Discovery and Development
3/4/2010 8:35:43 AM
FOSTER CITY, Calif.--(BUSINESS WIRE)--AB SCIEX, a global leader in life science analytical technologies, today announced that it is collaborating with the University of Geneva’s Mass Spectrometry Centre to create new workflows and analytical strategies intended to significantly improve drug discovery and development. This collaboration is focused on developing specific applications for use with a groundbreaking platform that will be the life science industry’s first mass spectrometry system to combine both qualitative and quantitative analysis at high resolution and high sensitivity with accurate mass. AB SCIEX will launch this system later this year.
comments powered by